| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50005 |
J-111 |
human |
blood |
HeLa markers* |
|
| 2 | general cells |
IFO50041 |
MBT2 |
mouse |
bladder |
bladder carcinoma |
|
| 3 | general cells |
IFO50248 |
IT-79MTNC3 |
mouse |
thymus |
thymic nurse cell, (BALB/c mouse) |
|
| 4 | general cells |
IFO50293 |
MA-89 |
mouse |
brain, cerebra |
Not immortalized cells. Limited life span. |
|
| 5 | general cells |
IFO50513 |
MTA |
human |
peripheral blasts |
leukemia, NK-like T cell line |
|
| 6 | general cells |
JCRB0075 |
SF-TY |
human |
skin |
normal fibroblast |
|
| 7 | general cells |
JCRB0126.1 |
KOSC-2 cl3-43 |
human |
oral floor |
Human tumor cells derived from oral cancer at stage III. The cells were originally cross contaminated with mouse cells but the mouse cells were eliminated in the JCRB cell bank and the cl3-43 subclone ID was applied to the cell name. |
|
| 8 | general cells |
JCRB0133 |
KHM-1B |
human |
pleural effusion |
myeloma, multiple, with hyperamylasemia. |
|
| 9 | general cells |
JCRB0139 |
TASK1 |
human |
chest wall mass/left |
Human cell line with primitive neuroectodermal tumor (Askin's tumor). |
|
| 10 | general cells |
JCRB0156 |
KHYG-1 |
human |
peripheral blood |
Human natural killer cell line with a p53 point mutation as a model for p53-associated leukemogenesis and a model for differentiation of NK/T cells. |
|
| 11 | general cells |
JCRB0160 |
LI90 |
human |
liver |
Ito (fat-storing) cells, stellate-shaped mesenchymal cells that exist in the space of Disse of the liver and contain many fat droplets in cytoplasm. |
|
| 12 | general cells |
JCRB0163 |
HL60(S) |
human |
peripheral blood |
Promyeloblastic cell line differentiated to neutrophils or macropahges by tumor promoters, vitamne D3 or cytekines. This HL60(S) has been independently obtained by Dr. Ishida,S. and Dr. Shudo,K. |
|
| 13 | general cells |
JCRB0186 |
OV3121ras4 |
mouse |
ovary |
Mouse ovarian granulosa cell tumor line with v-Ha-ras gene. |
|
| 14 | general cells |
JCRB0428 |
HuO9N2 |
human |
bone |
osteosarcoma |
|
| 15 | general cells |
JCRB0534 |
TIG-114 |
human |
skin |
skin, normal diploid fibroblast |
|
| 16 | general cells |
JCRB0740 |
NG-3Y1-T308 |
rat |
embryo/fetus whole body |
3Y1 derivative, transformed by MNNG, (Fischer rat) |
|
| 17 | general cells |
JCRB0819 |
SBC-5 |
human |
lung |
small cell carcinoma, intermediate |
|
| 18 | general cells |
JCRB1010 |
KMRC-1 |
human |
kidney |
Human tumor cell line from kidney. Clear cell renal carcinoma cell line. |
|
| 19 | general cells |
JCRB1027 |
SAT |
human |
oral cavity |
Human squamous cell carcinoma with non-metastatic cell line derived from oral cavity. |
|
| 20 | general cells |
JCRB1053 |
STC 1 |
human |
lung |
Human small cell lung carcinoma. |
|
| 21 | general cells |
JCRB1073 |
ASH-3 |
human |
cervical tissue |
Tumor cell line with multidrug registance obtained from rapidly growing cervical tumor(neck) diagnosed as an anaplastic thyroid carcinoma. |
|
| 22 | general cells |
JCRB1074 |
FU97 |
human |
stomach |
Human stomach cancer cell line with AFP production. |
|
| 23 | general cells |
JCRB1168 |
NCR-G3 |
human |
testis (mixed embrional carcinoma) |
Complex type germ cell tumor of human testis origin. |
|
| 24 | general cells |
JCRB1207 |
SV |
mouse |
skin (beta-gal deficient mouse) |
SV40 immortalized beta-galactosidase gene deficient mouse fibroblast cell line. Human disease animal model mouse (GM1 gangliosidosis) derived cell line. |
|
| 25 | general cells |
JCRB1222.02 |
HGH1.6.5 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
| 26 | general cells |
JCRB1222.05 |
HGH2.6.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
| 27 | general cells |
JCRB1311 |
ZEN |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against zearalenone. |
|
| 28 | general cells |
JCRB1316.1 |
OHP57.G6.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone. |
|
| 29 | general cells |
JCRB1319 |
PL-21 |
human |
white blood |
Human myeloid cell line derived from an acute promyelocytic leukemia. |
|
| 30 | general cells |
JCRB1332 |
NALL-1 |
human |
peripheral blood |
Human 'null' cell from ALL cell line. |
|
| 31 | general cells |
JCRB1342.04 |
MOR76.7F.16 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
| 32 | general cells |
JCRB1342.05 |
MOR83.3.10 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
| 33 | general cells |
JCRB1342.07 |
MOR124.2.2 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
| 34 | general cells |
JCRB1346 |
FLAM-76 |
human |
|
Interleukin-6-dependent human myeloma cell line from an agressive nonsecretory plasma cell leukemia. |
|
| 35 | general cells |
JCRB1347 |
KML-1 |
human |
pleural effusion |
Human B-cell lymphoma cell line. |
|
| 36 | general cells |
JCRB1357 |
1-1src |
mouse |
embryo, whole |
The src-transformed BALB/c 3T3 A31-1-1 variant cell lines were strongly tumorinenic and metastatic.(Strain problem was found. Refer Important Notice at cell detail page.) |
|
| 37 | general cells |
JCRB1358.07 |
SRBC-F31-2-11 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
| 38 | general cells |
JCRB1380 |
HBs320 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against HBs antigen. |
|
| 39 | general cells |
JCRB1384 |
STR-428 |
human |
ascites |
Human HHV-8 negative malignant effusion lymphoma (DLBCL). |
|
| 40 | general cells |
JCRB1571 |
F6B3 |
mouse |
brain |
Mouse cell line derived from mouse brain tumor. |
|
| 41 | general cells |
JCRB1595 |
KYAE-2 |
human |
esophagus |
Human esophageal adenocarcinoma cell line. |
|
| 42 | general cells |
JCRB1782 |
BALM-7 |
human |
bone marrow |
B cell leukemia cell line |
|
| 43 | general cells |
JCRB1784 |
BALM-8 |
human |
bone marrow |
B cell leukemia cell line |
|
| 44 | general cells |
JCRB1790 |
BALM-9N |
human |
peripheral blood |
B cell leukemia cell line |
|
| 45 | general cells |
JCRB1843 |
BALM-24 |
human |
peripheral blood |
B cell leukemia cell line, ALL-L3 cell line, t(8;14)(q24.1;q32) |
|
| 46 | general cells |
JCRB1857 |
OCUT-4 |
human |
thyroid |
human anaplastic thyroid cancer cell line |
|
| 47 | general cells |
JCRB2208 |
A9(Neo8) |
human chromosome-introduced |
skin |
contains human chromosome # 8 (MTA with Tottori Univ. is required.) |
|
| 48 | general cells |
JCRB4087 |
NCC-GCTB9-C1 |
human |
Right distal tibia |
Giant cell tumor cell line |
|
| 49 | general cells |
JCRB9003 |
NCTC Clone 929 |
mouse |
|
fibroblast, subclone of strain L, (C3H/An mouse) |
|
| 50 | general cells |
JCRB9033 |
STK1 |
mouse |
hybridoma |
anti-DNA polymerase alpha, IgG1 |
|
| 51 | general cells |
JCRB9083 |
LoVo |
human |
colon |
adenocarcinoma, carcinoembryonic antigen-producing |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.